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Objectives: To review the responses of advance directives signed by Jehovah’s Witness patients 
prior to undergoing surgery at a gynecologic oncology service.
Study design: A retrospective chart review of gynecologic oncology patients undergoing sur-
gery at a bloodless surgery center from 1998–2007 was conducted. Demographic, pathologic, 
and clinical data were recorded. The proportion of patients who accepted and refused various 
blood-derived products was determined and was compared to previously published results from 
a similar study of labor and delivery unit patients.
Results: No gynecologic oncology patients agreed to accept transfusions of whole blood, 
red cells, white cells, platelets, or plasma under any circumstance, whereas 9.8% of pregnant 
patients accepted transfusion (P=0.0385). However, 98% of gynecologic oncology patients 
agreed to accept some blood products, including fractions such as albumin, immunoglobulins, 
and clotting factors, while only 39% of pregnant patients agreed (P,0.0001). In addition, all 
gynecologic oncology patients (100%) accepted intraoperative hemodilution, compared to 55% 
of pregnant patients (P,0.0001).
Conclusion: Our results confirm the commonly held belief that the majority of Jehovah’s 
 Witness patients refuse to accept major blood components. However, Jehovah’s Witness patients 
at a gynecologic oncology service will accept a variety of blood-derived products (minor 
fractions) and interventions designed to optimize outcomes when undergoing transfusion-free 
surgery. Patients presenting to a gynecologic oncology service respond differently to advanced 
directives related to bloodless surgery, as compared to patients from an obstetrical service.
Keywords: Jehovah’s Witness, bloodless surgery, advanced directives
Introduction
Jehovah’s Witness patients present a significant challenge to the gynecologic 
surgeon. Because of their religious beliefs, Jehovah’s Witnesses typically do not 
accept transfusions of whole blood, red blood cells, white blood cells, platelets, and 
plasma. This ban on allogenic blood has been official church doctrine since 1945,1 
but more recently, the church has significantly modified its stance regarding this 
issue and currently does allow transfusion of minor fractions of blood based on 
individual preference.2
The field of bloodless surgery and medicine (patient blood management) has 
rapidly evolved over the past few decades. Starting in 1962, Ott and Cooley3 per-
formed more than 500 open-heart surgery procedures on Jehovah’s Witness patients 
without the use of blood transfusions. Methods of blood conservation and bloodless 
surgery continue to improve with the introduction of new clinical, surgical, and 
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pharmacologic strategies. Jehovah’s Witness patients and 
others wishing to avoid allogeneic transfusions now have 
access to many techniques designed to avoid allogeneic 
transfusion and to minimize procedure-related blood loss 
including normovolemic hemodilution and intraoperative 
autologous blood salvage (performed in a closed system 
without blood storage).4–8 According to the Society for the 
Advancement of Blood Management, there are currently 
approximately 100 bloodless surgery centers across the 
United States.9
Because the church encourages Jehovah’s Witness 
patients to decide whether or not to accept minor fractions 
of blood and other modern interventions, patients often 
rely on their own personal level of spirituality, family, and 
support network to reach a comfortable decision.2 Jehovah’s 
Witness patients presenting to our gynecologic oncology 
service through our patient blood management center 
are no  exception. They are asked to complete a detailed 
advanced directive as part of the preoperative counseling 
and management (Figure 1). Counseling with individuals 
trained in bloodless surgery has been a valuable resource 
for our patients.
We sought to review the responses of the advance 
directives by Jehovah’s Witnesses in order to gain a better 
understanding of our patients’ preferences with regards 
to interventions related to performing bloodless surgery. 
In addition, we wanted to compare our results to those 
from a recent study reporting responses given by pregnant 
Jehovah’s Witness patients admitted to a labor and deliv-
ery service in order to determine the potential differences 
among the pregnant population as compared to patients 
undergoing surgery at a gynecologic oncology service.2 
Importantly, the patients in the previous study by Gyamfi 
and Berkowitz2 did not have access to a hospital-based 
professional counseling service trained in bloodless surgery 
and medicine.
Methods
Patients undergoing surgical procedures at the gyneco-
logic oncology service at a patient blood management 
center were identified over a 9-year period from April 
1998–April 2007. This project was approved by the hospital 
Institutional Review Board.
For the cases identif ied, charts were reviewed for 
information regarding the patients’ general characteristics, 
as well as pertinent aspects of the surgeries performed. 
Data pertaining to preoperative, intraoperative, and 
postoperative interventions and techniques related to 
bloodless surgery were collected. Specifically, responses 
from the advance directives of Jehovah’s Witnesses were 
recorded.
All information collected was placed into a computer-
ized database. A two-samples t-test was used to compare the 
proportion of patients from our study who agreed to accept 
blood-derived products to that of patients presenting to a 
labor and delivery unit, as reported previously.2
Results
Forty-one patients were identif ied and accounted for 
43 procedures performed at the gynecologic oncology 
 service. The mean patient age was 58 (standard deviation 
[SD] ±13) years and all patients identified themselves as 
Jehovah’s Witnesses. Responses from advance directives 
of patients are reported in Table 1.
In general, patients received preoperative hemoglo-
bin optimization with iron and folic acid. Erythropoietin 
was used on an individualized basis when deemed indi-
cated by the attending physician and consented by the 
patient. The mean preoperative hemoglobin level was 
13.5 (SD ±1.9) g/dL. The most common procedures were 
laparotomy  (number [n] =31; 76%), salpingo-oophorectomy 
(n=30; 73%), hysterectomy (n=30; 73%), and lymph node 
dissection (n=17; 42%).  Laparoscopy (n=7) was performed 
in 17% of patients.  Twenty-nine cases (71%) were performed 
for malignancy including advanced ovarian, fallopian tube, 
or uterine cancers. Mean surgical and anesthesia times were 
155.1 (SD ±75.4) minutes and 217.7 (SD ±81.2) minutes, 
respectively.
Cell salvage was collected in 19 (46%) of cases, with 
four patients receiving reinfusion of cell salvaged blood. 
Of these four patients, three patients had malignancy 
and reinfusion of blood was performed using a leukocyte 
depletion filter in an effort to remove cancer cells (detailed 
outcomes of these three patients with known malignancy 
receiving cell salvage blood have been reported  previously6). 
 Intraoperative acute normovolemic hemodilution was per-
formed in 19 (49%) cases. Median blood loss was 200 mL 
(0–2,500 mL) and mean postoperative hemoglobin was 
11.3 (SD ±2.4) g/dL. Major intraoperative and postopera-
tive complications occurred in three patients (7.3%) and 
included hemorrhage (n=1), symptomatic anemia (n=2), 
necrotizing fasciitis (n=1), bowel perforation (n=1), and 
thromboembolic events (n=1). The median hospital stay 
was 4 days (range: 0–95 days).
Our data from the advanced directives show that none of 
the Jehovah’s Witness patients included in this study would 
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accept transfusions of whole blood, red cells, white cells, 
platelets, or plasma under any circumstances. Data regarding 
responses to minor fractions of blood and other interventions 
are summarized in Table 1.
We compared our subjects’ responses to previously 
published responses given by Jehovah’s Witness patients 
presenting to an obstetrical service.2 It is important to 
note that the obstetrical dataset we used for comparison 
was not data collected in this present study. In addition, 
the advanced directive used in the obstetrical service by 
Gyamfi and Berkowitz2 was not as detailed as the advanced 
directive offered to the gynecologic oncology patients in 
our study. The obstetrics advanced directive had five areas 
of consideration for patients to respond to: whole blood; 
some amount of blood products, or no blood; hemodilu-
tion; and cell salvage.2 The gynecologic oncologic service 
offered patients 14 areas of consideration despite not 
directly offering any major blood fractions (Figure 1). 
Of the Jehovah’s Witness patients that presented to the 
obstetrics service, 9.8% of respondents accepted whole 
Figure 1 Bloodless protocol patient instruction sheet.
Notes: The checklist is provided solely as a guide and should not be considered a legal document. This has been adapted from the Bloodless Medicine and surgery Program 
checklist at our institution.
Abbreviation: CVVH, continuous veno-venous hemofiltration.
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blood, 39.3% accepted some blood products, and 50.1% 
did not accept any blood or blood products.2 For autologous 
blood, 55% of obstetrics subjects accepted intraoperative 
hemodilution and 46% of obstetrics subjects accepted cell 
salvage.2
Discussion
The evolution of bloodless surgery and medicine now 
offers Jehovah’s Witness patients an organized approach 
to surgery designed to minimize blood loss and to avoid 
blood transfusions.4,8 Bloodless surgery is separated into 
three categories: preoperative; intraoperative; and postop-
erative  interventions.8 The preoperative process begins with 
a thorough history and a detailed physical  examination.10 
 Preoperative counseling with informed consent is of 
paramount importance in managing patients who desire to 
avoid allogeneic transfusions when undergoing surgical 
 procedures.4 In this regard, patients are asked to clearly 
document which, if any, minor or major fractions of blood 
they would accept, as well as which bloodless-related preop-
erative, intraoperative, and postoperative measures they will 
accept.4 Therefore, all bloodless patients are asked to fill out 
an advanced directive form (Figure 1) as part of the preopera-
tive management at our institution. A detailed discussion of 
the preoperative, intraoperative, and postoperative measures 
outlined in the advanced directive form as they relate to our 
study is provided.
During the preoperative management, hemoglobin levels 
should be optimized, and efforts should be made to correctly 
diagnose and treat any existing anemia.  Erythropoietin 
therapy, iron therapy, vitamin supplementation, and 
 administration of other medications are often useful in the 
preoperative setting and should be considered on an individ-
ual basis.8,10 Because erythropoietin contains a small amount 
of albumin, which may not be acceptable to certain Jehovah’s 
Witness patients, this medication is specifically addressed on 
the advanced directive form (Figure 1). Included in the pre-
operative management, the physician should also minimize 
blood draws and avoid medications that may interfere with 
platelet activity such as aspirin and other nonsteroidal anti-
inflammatory drugs.10 The use of pediatric tubes for blood 
draws may be appropriate, especially if a large number of 
laboratory tests are being performed.11 In select cases, the 
gynecologic surgeon may consider preoperative uterine artery 
embolization or balloon catheter placement by interventional 
radiology in order to minimize surgical blood loss.4
Intraoperative management of the bloodless patient is 
complex and requires a high level of technical skill and 
excellent communication between the surgical and anesthesia 
teams. Surgical approaches that reduce blood loss, such as 
handling tissue gently, recognizing and avoiding potential 
sources of bleeding, and rapidly controlling unexpected 
hemorrhage, are essential.10 Patient positioning is criti-
cal in order to maximize access to the surgical field from 
multiple approaches. We routinely perform our laparoscopic 
Table 1 responses from advance directives of Jehovah’s Witnesses
Number (%) 
41 patients
albumin 
 accept 
 refuse
 
40 (98%) 
1 (2%)
erythropoietin 
 accept 
 refuse
 
40 (98%) 
1 (2%)
immunoglobulins 
 accept 
 refuse
 
40 (98%) 
1 (2%)
clotting factors 
 accept 
 refuse 
 not answered
 
36 (90%) 
4 (10%) 
1
Fractional agents 
 accept 
 refuse 
 not answered
 
31 (89%) 
4 (11%) 
6
Topical tissue adhesives/hemostatics 
 accept 
 refuse 
 not answered
 
39 (98%) 
1 (2%) 
1
cryoprecipitates 
 accept 
 refuse 
 not answered
 
35 (88%) 
5 (12%) 
1
intraoperative hemodilution and fractionation 
 accept 
 refuse
 
41 (100%) 
0 (0%)
hemodialysis equipment 
 accept 
 refuse
 
41 (100%) 
0 (0%)
intraoperative autologous blood salvage 
 accept 
 refuse
 
40 (98%) 
1 (2%)
Postoperative blood salvage/reinfusion 
 accept 
 refuse 
 not answered
 
37 (100%) 
0 (0%) 
4
cardiopulmonary bypass 
 accept 
 refuse 
 not answered
 
36 (100%) 
0 (0%) 
5
Organ donation 
 accept 
 refuse 
 not answered
 
8 (50%) 
8 (50%) 
25
Organ transplantation 
 accept 
 refuse 
 not answered
 
8 (50%) 
8 (50%) 
25
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and open abdominal gynecologic surgeries in the dorsal 
lithotomy position using Allen stirrups to allow access for 
both abdominal and vaginal surgical approaches. This posi-
tion also reduces arterial pressure around the surgical site 
and facilitates venous drainage away from the site.10 Other 
important intraoperative techniques include acute normov-
olemic hemodilution and intraoperative autologous transfu-
sion (which may be acceptable to some Jehovah’s Witness 
patients when performed in a closed system without blood 
storage).10,12 Because these interventions are not accepted by 
all patients, they are specifically addressed in the advanced 
directive form (Figure 1). Importantly, we previously demon-
strated the safety and efficacy of cell salvage using leukocyte 
depletion filters in patients with malignancy as a method to 
prevent hematogenous dissemination of tumor cells.6 In addi-
tion, we have recently demonstrated that laparoscopic blood 
collection is not inferior to the standard Yankauer method for 
cell salvage collection used in open surgery. Therefore, cell 
salvage blood collection should be considered in patients 
undergoing laparoscopic procedures when significant blood 
loss is anticipated.7
Postoperative measures in bloodless surgery include tol-
erance of anemia and minimization of blood draws. Patients 
should be monitored closely to check for bleeding and 
adequate oxygenation.4,10 If the patient requires intensive care, 
excellent communication with the intensive care unit staff 
is crucial to the success of the patient.8 The use of pediatric 
blood tubes should be considered when appropriate, and the 
judicious use of intravenous iron and erythropoietin should 
also be considered in the postoperative period.8,11,13,14 If acute 
postoperative bleeding is suspected, the surgeon should con-
sider reoperation promptly to identify and treat the source of 
bleeding.8 Although we do not routinely follow hemoglobin 
levels in the postoperative period in a stable patient, studies 
have shown a low risk of postoperative mortality in upper 
nadir hemoglobin ranges of 7–8 g/dL and much higher risk 
in lower ranges.15
We demonstrate that differences in advanced directive 
responses exist between obstetrics patients and gynecologic 
oncology patients. Fewer obstetrics patients accepted minor 
fractions of blood than did gynecologic oncology patients; 
however, more obstetric patients accepted whole blood than 
did the gynecologic patients. Also, a smaller percentage of 
obstetric patients accepted hemodilution and/or cell salvage 
than did the gynecologic oncology patients.
One possible explanation for the discrepancy in 
advanced directive preferences between the two study 
populations is inherent to the characteristics of the study 
populations themselves (obstetrics versus gynecologic 
oncology).2 For example, the obstetrics patients were 
younger than the gynecologic oncology patients and 45% 
of the obstetrics patients were prima gravida.2 Intuitively, 
maternal instinct and a sense of responsibility of wanting 
to take care of a newborn may account for why this popula-
tion would be more likely to accept whole blood.
There are many factors that influence individual patient 
responses on the advanced directive form. The individual 
freedom that the Jehovah’s Witness church provides Jehovah’s 
Witness patients in accepting or rejecting minor blood fractions 
or modern interventions allows for patients to incorporate their 
own values and the advice of their own support network in the 
decision-making process.2 In addition, the technical language 
of an advanced directive may be difficult for certain individuals 
to comprehend, which could lead to inaccurate documenta-
tion of a patient’s wishes. Thus, when completing advanced 
directives, patients should be counseled by physicians and/or 
trained professionals that are thoroughly familiar with the field 
of patient blood management. The counselor must understand 
both the options presented in the advanced directive and the 
patient’s beliefs, as not all Jehovah’s Witness patients reject 
blood or all blood products.2 An attending or resident physician 
not thoroughly familiar or up to date with bloodless medicine 
and surgery techniques may not be able to take such vagaries 
into account when counseling patients.
With this in mind, another explanation for the differences 
in data between the obstetrics service and the gynecologic 
oncology service could be the nature of the counseling 
services each hospital or hospital service offered to their 
patients. The patients that presented to the gynecologic 
oncology service were admitted to an established blood-
less surgery center, with dedicated staff members that were 
trained specifically for counseling and aiding in the care of 
Jehovah’s Witness patients. The patients that presented to 
the obstetrical service did not have access to a specialized 
counseling staff member. Thus, the obstetrical patients were 
largely dependent on the direction of the resident and attend-
ing physicians on the obstetrical service, presumably with 
little or no specialized training in the field of patient blood 
management. Without the help of dedicated support staff 
specializing in bloodless medicine and surgery, the obstetri-
cal patients may have had less guidance and found it more 
difficult to make such important decisions about their care.
One more possible explanation for the differences in the 
responses among patient populations is that the advanced 
directive used by the gynecologic oncology service was much 
more specific and detailed than the advanced directive used by 
the obstetrical service in the study by Gyamfi and Berkowitz.2 
The greater number of queries on the advanced directive made 
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available to the oncology study population may have allowed 
the patients to feel more comfortable, whereas the obstetrical 
patients may have felt they had fewer choices available to them 
if a complication were to arise.
The limitations of our study include having a small 
sample size for our study population, using previously pub-
lished data from a historical cohort as a comparison, and the 
inherent biases associated with retrospective chart reviews. 
In addition, our study encompasses a long time period 
(1998–2007), during which significant policy changes had 
occurred at the Watchtower Society. Specifically, in June 
2000, the Jehovah’s Witness church organization issued a 
communication stating that the society would no longer 
disfellowship members who accepted blood, but instead 
concluded that a member’s acceptance of blood would be 
regarded as a member’s voluntary wish to no longer be one 
of the Jehovah’s Witnesses.16 The new policy also addressed 
minor fractions of blood stating that, “when it comes to 
fractions of any of the primary components, each Christian, 
after careful and prayerful meditation, must conscien-
tiously decide for himself ”.16 These policy changes may 
have resulted in patients feeling more comfortable with the 
idea of accepting minor fractions of blood and could have 
influenced our results especially with regards to patients 
undergoing surgery in our blood management program 
from 2000 onward. These policy changes also highlight 
the importance of patient confidentiality in this patient 
population, where personal decision making and commu-
nity judgment had often previously overlapped. Finally, the 
fact that patients in our study were likely referred to (or 
specifically sought out treatment at) a bloodless surgery 
center may signify that we had a more religious population, 
and therefore may bias our results toward the direction of 
blood refusal.
Conclusion
In conclusion, completion of an advanced directive is 
an essential component of preoperative patient blood 
 management. By comparing responses on advanced direc-
tives from different patient populations, we have shown that 
significant variations in responses exist among Jehovah’s 
Witness patients. Although several factors may account for 
the differences noted in this study, we believe that counseling 
by a dedicated support staff member trained in the field of 
bloodless surgery plays a critical role.  Therefore,  counseling 
performed by individuals with a strong background in 
blood management interventions and techniques should be 
readily available to all patients wishing to avoid allogeneic 
transfusions.
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